Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation
Follows recent equity financing, resulting in debt and equity gross proceeds of $15.2 million
SILVER SPRING, Md., Dec. 15, 2022 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq:AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and the patients they treat, today announced that it has received an additional $4 million term loan from SWK Holdings Corporation, a healthcare-focused investment firm.